Inside informationEnglish
VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Valbiotis
- Filed
- 14/01/2025, 17:45
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 006710_20250114